Lunac Therapeutics
PrivateLast Round
VC Round
May 13, 2021
Total Funding Raised
$7.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Lunac Therapeutics is a drug discovery company developing next-generation oral anticoagulants to treat and prevent thrombotic events without the bleeding risk associated with current therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lunac Therapeutics Comparables
Compare Lunac Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aronora, Inc. | 84% | |
| Anthos Therapeutics | 77% | |
| Bayer AG | 74% | |
Lunac Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 13, 2021 | ||||
| Grant | Dec 12, 2019 | ||||
| Series A | Nov 14, 2019 |
Lunac Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Leeds | Series A |
| Epidarex Capital | VC Round, Series A |
| Innovate UK | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 36% MoM.
- Jun 18, 2026
Monthly visitors increased 81% MoM.
Lunac Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lunac Therapeutics's valuation, stock price, and market status.